
21 Sep
2020
21 Sep
'20
4:06 p.m.
On Mon, 21 Sep 2020 13:11:17 +1200, Peter Reutemann quoted:
'Two professors at the University of Massachusetts have co-authored a new essay explaining how open source licensing "could keep Big Pharma from making huge profits off taxpayer-funded research" in the international, multi-billion-dollar race for a Covid-19 vaccine:
Note that “taxpayer-funded”. Most of the research done into new medicines, vaccines and the like is done by Government-funded or nonprofit institutes, yet it is private companies that get to patent a lot of the results and make obscene profits off them.